Nuria Mulet
Badalona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial).
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 15, 2022
Up-to-date role of aflibercept in the treatment of colorectal cancer.
Journal: Expert opinion on biological therapy
Published: June 04, 2021
BRAF, MEK and EGFR inhibition as treatment strategies in BRAF V600E metastatic colorectal cancer.
Journal: Therapeutic advances in medical oncology
Published: June 23, 2020
Incorporating traditional and emerging biomarkers in the clinical management of metastatic colorectal cancer: an update.
Journal: Expert review of molecular diagnostics
Published: June 20, 2020
Molecular subtypes and the evolution of treatment management in metastatic colorectal cancer.
Journal: Therapeutic advances in medical oncology
Published: January 29, 2020
Triple-drug chemotherapy regimens in combination with an anti-EGFR agent in metastatic colorectal cancer - prospects from phase II clinical trials.
Journal: Expert opinion on investigational drugs
Published: March 25, 2019
Evaluating trifluridine + tipiracil hydrochloride in a fixed combination (TAS-102) for the treatment of colorectal cancer.
Journal: Expert opinion on pharmacotherapy
Published: March 15, 2018
Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer.
Journal: Science (New York, N.Y.)
Published: December 02, 2016
Showing 1-12 of 12
Last Updated: 09/26/2026